by cesarean section. She was diagnosed with placenta percreta by magnetic resonance imaging with a high suspicion that there was invasion into the muscularis of the bladder (Figure 1 ). Therefore, cesarean section was planned at 33 weeks of gestation. However, at 27 weeks of gestation, she underwent an emergency cesarean section due to vaginal bleeding and an intrauterine infection. We planned a cesarean section without exfoliating the placenta and cesarean hysterectomy. Pre-operative laboratory data are shown in Table 1 . General anesthesia was induced using propofol, remifentanil, and rocuronium and anesthesia was maintained using propofol, fentanyl, and remifentanil. Figure 2 shows the anesthetic chart including hemodynamics and laboratory data. During the surgery, because the uterine surface was highly vascularized due to the placenta percreta, the decision was made to avoid surgical resection of the placenta and to directly dissect the uterine base with a vertical incision and perform a complete hysterectomy and partial cystectomy. However, hemostasis became difficult because the bladder invasion by the placenta was abundant. Bleeding was ultimately controlled following bilateral internal iliac artery embolization. Furthermore, we used catecholamines (dopamine and norepinephrine), a cell salvage device (Cell Saver " ! ; Haemonetics Japan) and a rapid infuser (LEVEL 1 SYSTEM 1000 " ! ; Smith Medical Japan Ltd.) for hemodynamic stabilization. Intra-operative bleeding was 47,000 mL and total anesthesia time was 12 h and 47 min. A total of 120 units of red blood cells, 90 units of fresh frozen plasma, and 100 units of platelets were transfused. After the surgery, the patient was transferred to the intensive care unit and was extubated 9 hours later. Post-operative laboratory data are also shown in Table 1 . She was discharged on the 32th postoperative day without major complications.
The baby (898 g) was born 7 min after the operation had started and was intubated immediately after birth with Apgar scores of 1 and 5 at 1 minute and 5 minutes, respectively. The baby was extubated 17 days after birth and discharged after the 95th day. Figure 1 . Magnetic resonance imaging of the plevis revealed invasion into the bladder by the placenta (red arrow). 
DISCUSSION
Placenta percreta is a rare subtype of placenta accreta in which the placenta invades the entire uterine wall and affects the adjacent organs (Table  2) . It is a condition with a high surgical risk and generally requires an obstetric hysterectomy. Placenta accreta has been reported to have up to a 7% mortality rate as well as intra-operative and postoperative morbidity associated with massive blood transfusions, infection, ureteral damage, and fistula formation (2) . Prior delivery by cesarean section is a risk factor for placenta accreta. According to a report by Sumigama et al. (3) , among 59,008 deliveries, 408 cases were diagnosed as placenta previa ; of these, 18 cases were placenta increta and 5 of placenta percreta. Mean intra-operative blood loss was 3,630 !2,216 mL (increta) and 12,140 !8,343 mL (percreta). One patient with placenta percreta died of hemorrhage (3). In 1997, Dubois et al. reported that temporary balloon occlusion of the bilateral internal iliac artery is a method to control bleeding during cesarean hysterectomy for placenta percreta (4). However, in this emergency case, the patient presented with vaginal bleeding and had an intrauterine infection, preventing any pre-operatively planning. Ultimately, bilateral internal iliac artery embolization was performed intra-operatively to control hemorrhaging and achieve hemodynamic stability. Ideally, multidisciplinary pre-operative planning with the departments of obstetrics and gynecology, radiology, and anesthesiology will be optimal in future cases.
A decrease in fibrinogen is one of the leading factors involved in postpartum massive hemorrhage. Bleeding of !2,000 mL ; can result in dilutional coagulopathy. When massive hemorrhage occurs, fibrinogen is the first coagulation factor that becomes depleted resulting in coagulopathy. This is because other coagulation factors can deplete up to 80% of normal concentrations before coagulopathy is observed, whereas fibrinogen can only lose up to 60% of normal concentrations (100 mg/dL) before coagulopathy (5). Fresh frozen plasma (FFP) is used to increase the fibrinogen concentrations. However, when massive hemorrhaging persists, administration of FFP cannot be expected to effectively supplement the fibrinogen concentrations (6) . Moreover, there is a report that administration of a large quantity of FFP is associated with acute lung injury (7) . In this case, although the patient did not develop acute lung injury, we should prepare a cryoprecipitate by concentrating FFP to 10 times, when massive hemorrhage was expected (8) .
Cell Saver ! ! is a cell salvage device used during surgery to avoid allogeneic transfusions and the elevation of serum potassium concentration. Cell salvage has been used in obstetrics to a limited degree because of the fear of amniotic fluid embolism although the exact mechanism is still unclear. In contrast, leukocyte depletion filtering of cell-salvaged blood obtained from cesarean section reduces amniotic fluid components to a concentration equivalent to maternal venous blood (9) . This device has been reportedly used safely in !400 cases (4, 10) . In this case, the patient did not develop an amniotic fluid embolus. Moreover, Cell Saver ! ! reduced the need for allogeneic transfusions and avoided the elevation of serum potassium concentration. During surgery the patient's serum potassium concentration increased up to 7.6 mmol/L, but returned to a normal concentrations after using this device.
We describe a difficult case of placenta percreta with massive hemorrhage, where transfusions alone were not sufficient to maintain hemodynamics. The use of a cell salvaging device and rapid infuser, which are not routinely available during these procedures were required to maintain hemodynamic stability. Ultimately, it is critical to have multidisciplinary pre-operative discussions regarding strategic planning and potential complications in difficult cases such as these. Furthermore, pre-operative preparation of a Cell Saver ! ! and LEVEL 1 SYSTEM 1000
with appropriate staffing is essential in cases where massive blood loss is expected.
